RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

True, but it means they have this motivator at their disposal. When you think about how little data were actually conveyed at the RD-2 presentation, it isn't at all clear to me why generating the bottom-line numbers for RD-1 is so time-consuming.

My point is that if it takes weeks and weeks (assuming that they have the data in hand) it's because they want to drag it out.

This is a study with 16 participants, with VE55 as one number they need to measure, and another number that is probably equally straight-forward as an indication of analgesia preservation. How hard is the statistical analysis of these data?